Fusion event
HBV-chr19 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TTTACCGCTGTTACCAATTTTCTTTTGTCTTTGGGTATACATTTAAACCCTAACAAAACAAAGAGATGGGGTTACTCTCTAAATTTTATGGGTTATGTCA| |TTGGATGTTATGGGTCCTTGCCACAAGAACACATCATACAAAAAATCAAAGAATGTTTTAGAAAACTTCCTATTAACAGGCCTATTGATTGGAAAGTATG
End
34444241/33953336 (Hg38)
Nearest miRNA
hsa-mir-10395/Upstream/13553982; hsa-let-7e/Downstream/1169364;
Upstream sequence
ATTGCTCCAGAGGACATGGCCACAGCTGCTCCCTTGCAGGCTGGTGGGCTTGACCTCACTGAGAACTGGGAATGACCTCTGCGTCCTTCACATTCCAGCA
Downstream sequence
GCTTCCAGTGGAGCTTGGAAGGTATTTTCTTTTAGCATTGGAGACCAGTTCTTTAATGGATGGAAAAAAAAAAAAAGTCTTGTGAAGGGAAGACTTAGAT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.